BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers

Huong D. Meeks, Honglin Song, Kyriaki Michailidou, Manjeet K. Bolla, Joe Dennis, Qin Wang, Daniel Barrowdale, Debra Frost, Lesley McGuffog, Steve Ellis, Bingjian Feng, Saundra S. Buys, John L. Hopper, Melissa C. Southey, Andrea Tesoriero, Paul A. James, Fiona Bruinsma, Ian G. Campbell, Annegien Broeks, Marjanka K. SchmidtFrans B. L. Hogervorst, Matthias W. Beckman, Peter A. Fasching, Olivia Fletcher, Nichola Johnson, Elinor J. Sawyer, Elio Riboli, Susana Banerjee, Usha Menon, Ian Tomlinson, Barbara Burwinkel, Ute Hamann, Frederik Marme, Anja Rudolph, Ramunas Janavicius, Laima Tihomirova, Nadine Tung, Judy Garber, Daniel Cramer, Kathryn L. Terry, Elizabeth M. Poole, Shelley S. Tworoger, Cecilia M. Dorfling, Elizabeth J. van Rensburg, Carl Blomqvist, Sofia Khan, Heli Nevanlinna, Liisa M. Pelttari, Kristiina Aittomäki, Ralf Butzow, EMBRACE, kConFab Investigators, Australia Ovarian Canc Study Grp, HEBON, GEMO Study Collaborators, OCGN, PRostate Canc Assoc Grp

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Originalspråkengelska
Artikelnummer315
TidskriftJournal of the National Cancer Institute
Volym108
Nummer2
Antal sidor10
ISSN0027-8874
DOI
StatusPublicerad - feb. 2016
MoE-publikationstypA1 Tidskriftsartikel-refererad

Vetenskapsgrenar

  • 3123 Kvinno- och barnsjukdomar
  • 3122 Cancersjukdomar

Citera det här